| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Fortress Biotech, Inc. operates as a biopharmaceutical firm dedicated to the development and commercialization of a diverse range of pharmaceutical and biotechnology products. The company currently offers a portfolio of dermatological treatments. These include Ximino and Targadox, both formulated to address various forms of acne (ranging from moderate-to-severe inflammatory lesions to severe cases). Other products in this segment are Exelderm cream for fungal skin infections like ringworm and jock itch, Ceracade for dry skin conditions, …
Over the last 12 months, insiders at Fortress Biotech, Inc. have bought $0 and sold $0 worth of Fortress Biotech, Inc. stock.
On average, over the past 5 years, insiders at Fortress Biotech, Inc. have bought $2.76M and sold $15,575 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 763,359 shares for transaction amount of $1.4M was made by ROSENWALD LINDSAY A MD (PRESIDENT, CEO & CHAIRMAN) on 2024‑09‑23.
| 2024-09-23 | ROSENWALD LINDSAY A MD | PRESIDENT, CEO & CHAIRMAN | 763,359 4.3054% | $1.84 | $1.4M | +26.57% | ||
| 2024-07-11 | ROSENWALD LINDSAY A MD | President, CEO & Chairman | 5,000 – | $7.48 | $37,418 | -9.14% | ||
| 2024-07-10 | Jin David | Chief Financial Officer | 500 – | $7.50 | $3,750 | +2.29% | ||
| 2024-07-09 | ROSENWALD LINDSAY A MD | President, CEO & Chairman | 5,000 – | $7.39 | $36,971 | +3.78% | ||
| 2024-07-08 | ROSENWALD LINDSAY A MD | President, CEO & Chairman | 5,000 – | $7.35 | $36,765 | +1.71% | ||
| 2024-06-28 | ROSENWALD LINDSAY A MD | President, CEO & Chairman | 20,000 0.0943% | $1.64 | $32,724 | +4.09% | ||
| 2024-05-20 | Sale | Klein Dov | director | 10,000 0.0504% | $1.89 | $18,900 | -9.23% | |
| 2024-05-16 | ROSENWALD LINDSAY A MD | President, CEO & Chairman | 10,000 0.0532% | $1.76 | $17,589 | +1.14% | ||
| 2024-01-05 | ROSENWALD LINDSAY A MD | President, CEO & Chairman | 50,000 0.2671% | $2.38 | $118,770 | -23.76% | ||
| 2023-11-14 | ROSENWALD LINDSAY A MD | President, CEO & Chairman | 1.57M 1.4832% | $1.70 | $2.66M | +41.67% | ||
| 2023-11-14 | WEISS MICHAEL S | See Remarks | 147,058 0.1391% | $1.70 | $249,999 | +41.67% | ||
| 2023-09-26 | ROSENWALD LINDSAY A MD | President, CEO & Chairman | 100,000 0.0734% | $0.28 | $28,330 | -54.29% | ||
| 2023-08-18 | ROSENWALD LINDSAY A MD | President, CEO & Chairman | 10,000 – | $9.34 | $93,400 | -70.38% | ||
| 2023-08-17 | ROSENWALD LINDSAY A MD | President, CEO & Chairman | 10,000 – | $11.75 | $117,500 | -68.13% | ||
| 2023-02-10 | ROSENWALD LINDSAY A MD | President, CEO & Chairman | 2.4M 2.5829% | $0.83 | $2M | -32.89% | ||
| 2023-02-10 | WEISS MICHAEL S | See Remarks | 1.2M 1.2914% | $0.83 | $999,999 | -32.89% | ||
| 2023-02-10 | LOBELL J JAY | director | 299,401 0.3229% | $0.83 | $250,000 | -32.89% | ||
| 2023-02-10 | Jin David | Chief Financial Officer | 35,928 0.0387% | $0.83 | $30,000 | -32.89% | ||
| 2023-02-10 | Rowinsky Eric K | director | 11,976 0.0129% | $0.83 | $10,000 | -32.89% | ||
| 2023-02-10 | Lu Lucy | director | 11,976 0.0129% | $0.83 | $10,000 | -32.89% |
| ROSENWALD LINDSAY A MD | PRESIDENT, CEO & CHAIRMAN | 3657264 10.966% | $7.1M | 35 | 1 | +1.65% |
| LOBELL J JAY | director | 1635401 4.9036% | $3.17M | 4 | 0 | <0.0001% |
| WEISS MICHAEL S | See Remarks | 1130520 3.3898% | $2.19M | 3 | 0 | +30.36% |
| Rowinsky Eric K | director | 931976 2.7944% | $1.81M | 1 | 5 | <0.0001% |
| Lorenz Kevin | director | 214582 0.6434% | $416,289.08 | 2 | 0 | |
| Hunter Robyn | Chief Financial Officer | 163877 0.4914% | $317,921.38 | 1 | 3 | +7.65% |
| Lu Lucy | director | 133379 0.3999% | $258,755.26 | 8 | 0 | +10.5% |
| COOPER GLENN L MD | See Remarks | 43811 0.1314% | $84,993.34 | 2 | 0 | +12.64% |
| Weisman Harlan F | Chairman and CEO | 30000 0.09% | $58,200.00 | 2 | 0 | |
| SANDAGE BOBBY W PHD | President and CEO | 25311 0.0759% | $49,103.34 | 4 | 0 | +14.63% |
| Hehenberger Karin M. | See Remarks | 20925 0.0627% | $40,594.50 | 1 | 0 | +12.64% |
| Hoenlein Malcolm | director | 16667 0.05% | $32,333.98 | 2 | 0 | +44.66% |
| Beerman Noah D | Executive VP and COO | 15000 0.045% | $29,100.00 | 3 | 0 | +15.32% |
| RITTER DALE | SVP & Chief Accounting Officer | 11503 0.0345% | $22,315.82 | 2 | 0 | +12.64% |
| Jin David | Chief Financial Officer | 500 0.0015% | $970.00 | 3 | 0 | <0.0001% |
$5,831,763 | 118 | -33.78% | $66.68M | |
$9,405,928 | 107 | 12.61% | $74.85M | |
Fortress Biotech, Inc. (FBIO) | $17,525,882 | 60 | 5.22% | $64.7M |
$103,288,323 | 51 | 4.78% | $56.52M | |
$19,705,388 | 47 | 86.26% | $67.15M |
| Increased Positions | 30 | +42.25% | 2M | +45.69% |
| Decreased Positions | 31 | -43.66% | 534,372 | -12.16% |
| New Positions | 14 | New | 2M | New |
| Sold Out Positions | 17 | Sold Out | 262,456 | Sold Out |
| Total Postitions | 70 | -1.41% | 6M | +33.54% |
| Vanguard Group Inc | $3,830.00 | 3.07% | 950,327 | +97,405 | +11.42% | 2025-09-30 |
| Summit Financial, Llc | $1,792.00 | 1.44% | 444,748 | -571,096 | -56.22% | 2025-09-30 |
| Susquehanna International Group, Llp | $1,435.00 | 1.15% | 356,178 | +310,543 | +680.49% | 2025-09-30 |
| Shikiar Asset Management Inc | $1,122.00 | 0.9% | 278,469 | 0 | 0% | 2025-09-30 |
| Geode Capital Management, Llc | $985.00 | 0.79% | 244,421 | +9,631 | +4.1% | 2025-09-30 |
| Northern Trust Corp | $889.00 | 0.71% | 220,637 | +127,412 | +136.67% | 2025-09-30 |
| Sculptor Capital Lp | $842.00 | 0.67% | 208,900 | +208,900 | New | 2025-09-30 |
| Kestra Advisory Services, Llc | $793.00 | 0.64% | 196,875 | -135,123 | -40.7% | 2025-09-30 |
| Blackrock, Inc. | $765.00 | 0.61% | 189,794 | +57,708 | +43.69% | 2025-09-30 |
| Hb Wealth Management, Llc | $484.00 | 0.39% | 120,175 | +120,175 | New | 2025-09-30 |